Clinical research professionals should be aware of the difficulties that biotech companies have in gaining access to high quality samples.
The funding for, and the number of, clinical trials for chronic kidney disease lag significantly behind its incidence and behind other diseases.
This column delivers news from academic medical centers pursuing clinical research activities vital to the advancement of healthcare.
Researchers say they have identified the attributes of a successful real-world evidence study that contribute to an accelerated or full drug approval.
With robust community engagement, equitable inclusion in vaccine trials can make a powerful impact on the health of underrepresented communities.